Full-time US Stock Trader | Focus on High-Potential Growth Stocks and Explosive Growth Opportunities | Capture 10x Stocks | Daily US Stock Insights and Real-Tim
Congratulations to everyone who joined us on this ride! 🚀
We’ve won again!
January: Semiconductor Test Equipment Leader → +51%
February: Fiber Optic Communications Leader → +46%
March: Heavy Industry/Aerospace Giant → +59%
April: Memory Chip Leader → +166%
Our next major target—with multi-bagger potential—has been locked in!
A core investment opportunity at the intersection of Next-Gen U.S. Healthcare and 6G Intelligent Infrastructure.
Through deep integration with 6G communication infrastructure, this company is poised to fully empower telemedicine, real-time AI diagnostics, remote surgery, and the digital transformation of healthcare—seizing the first-mover advantage in the future's multi-trillion-dollar intelligent healthcare market!
Current Share Price: $3.25
Target Forecast: $93.30 (Approx. 28x Potential)
On March 30, the S&P 500 index fell 7% year-to-date, marking one of its worst starts in history.
However, after experiencing the largest eight-week rally in history (a gain of 17%), the index is now up more than 10% year-to-date.
@nateinthewild@Yeah_Dave Seeing this kind of real-life reflection is truly inspiring. It's not about getting rich overnight, but the result of two years of continuous learning and execution.
Many are still looking for the next Nvidia.
But the companies that are truly likely to multiply in value are often smaller AI infrastructure companies.
$SOUN $BBAI $SIVE
Anyone else stocking up on RKLB like me? Q1 revenue reached $200 million, a 64% year-over-year surge, with a record-high order backlog of $2.2 billion. The Neutron rocket is also scheduled for its maiden flight this year. SpaceX is planning an IPO; what are your thoughts?
@mercado29 I couldn't agree more! RKLB's Q1 revenue hit a record high of $200M (+64% YoY), and that $2.2 billion backlog is truly impressive. If Neutron's maiden flight goes smoothly this year, it will undoubtedly serve as a major catalyst.
A leading semiconductor company specializing in AI power management and next-generation chips is brewing a major strategic partnership. Short-term target (next week): $3.92 – $9.80 Long-term target (within months): Potentially reaching above $38.70.
@rp111113@TheMoonCarl Cannabis has been beaten down for years. If federal rescheduling finally happens, $MSOS could see massive re-rating. High risk, high reward setup.
@Bas86enschede@TheMoonCarl Inflation-adjusted valuations are still at extreme levels. Even with inflation, current multiples are historically very stretched. The chart already accounts for nominal reality.
@audienoelle@TheMoonCarl True, valuation is one thing but making money is about timing, risk management, and having an edge. Smart money always finds a way regardless of the headline valuation.